Does Insurance Cover Ketamine Therapy? Here’s What to Know

Insurance Coverage for IV Ketamine Therapy

IV ketamine infusions are one of the most common approaches to treatment, but they are also the least likely to be covered by insurance.

Why IV Ketamine Is Considered Off-Label

Although IV ketamine is widely used for mental health conditions, it is not FDA-approved for depression, anxiety, or PTSD. Instead, it is considered “off-label use,” meaning insurance companies typically do not reimburse for it.

Typical Out-of-Pocket Costs

Because of this, patients often pay out of pocket. Costs for IV ketamine infusions usually range between $400 and $800 per session. A full induction phase may add up to several thousand dollars, not including maintenance treatments.

Exceptions and Advocacy

Some insurers have made rare exceptions on a case-by-case basis, especially when a psychiatrist provides detailed documentation. However, these approvals are the exception rather than the rule.

Insurance Coverage for Spravato (Esketamine)

Spravato, the nasal spray form of esketamine, is FDA-approved for treatment-resistant depression and major depressive disorder with suicidal ideation. Because of this approval, insurance coverage is much more common than with IV ketamine.

Coverage Through Certified Clinics

Many insurance plans will cover Spravato when it is administered in a certified clinic under provider supervision. Patients must remain in the clinic for at least two hours after dosing for monitoring, as required by FDA guidelines.

Copays and Deductibles Still Apply

Even with coverage, patients may be responsible for copays, deductibles, or session limits depending on their plan. Coverage may also require prior authorization before starting treatment.

Accessibility of Spravato

Because Spravato is FDA-approved, it is more widely recognized by insurance companies. For patients seeking covered options, it may be the most accessible form of ketamine therapy.

Factors That Influence Insurance Coverage

Coverage for ketamine therapy depends on more than just whether a treatment is FDA-approved. Several factors play a role in determining whether insurance will pay for all or part of the costs.

Diagnosis and Documentation

Insurance companies often require evidence of treatment-resistant depression or another approved condition. Documentation from a psychiatrist is essential to support coverage.

Type of Insurance Plan

Private insurance, Medicare, and Medicaid may all have different rules regarding coverage. Some employer-based plans are more flexible, while others are highly restrictive.

Provider Network Status

Coverage may also depend on whether the clinic or provider is in-network with the patient’s plan. Out-of-network care often results in higher out-of-pocket expenses.

Combination With Other Care

Some insurers require that ketamine therapy be paired with approved therapies or medication management to qualify for coverage.